Iron overload in myelodysplastic syndromes: A Canadian consensus guideline

被引：40

作者：

Wells, Richard A. ^{[1
]}

Leber, Brian ^{[2
,3
]}

Buckstein, Rena ^{[1
]}

Lipton, Jeffrey H. ^{[4
]}

Hasegawa, Wanda ^{[5
]}

Grewal, Kujit ^{[6
]}

Yee, Karen ^{[4
]}

Olney, Harold J. ^{[7
]}

Larratt, Loree ^{[8
]}

Vickars, Linda ^{[9
]}

Tinmouth, Alan ^{[10
]}

机构：

[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Myelodysplast Syndromes Program, Toronto, ON M4N 3M5, Canada

[2] Hamilton Hlth Sci, Hamilton, ON, Canada

[3] McMaster Univ, Hamilton, ON, Canada

[4] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada

[5] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[6] Hlth Sci Ctr, St John, NF, Canada

[7] Hop Notre Dame de Bon Secours, CHU Montreal, Montreal, PQ H2L 4K8, Canada

[8] Univ Alberta, Edmonton, AB, Canada

[9] BC Canc Agcy, Vancouver, BC, Canada

[10] Ottawa Hosp, Ottawa, ON, Canada

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 09期

关键词：

myelodysplastic syndromes; iron overload; secondary hemosiderosis; iron chelation; deferoxamine; deferasirox; desferal; exjade; deferriprone; ferriprox; transfusion; prognosis; guideline;

D O I：

10.1016/j.leukres.2008.02.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In December 2005, 11 Canadian hematologists met to develop an evidence-based clinical practice guideline that would address the diagnosis, monitoring, management, and rationale for the treatment of transfusional iron overload in patients with myelodysplastic syndromes (MDS). This Expert Panel consisted of hematologists from across Canada, each with an active practice in a major population centre or a rural area. Based on an extensive literature search and years of clinical experience, their mandate was to address common clinical practice questions, particularly why treat, whom to treat, when to initiate treatment, and how to treat iron overload in patients with MDS. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：1338 / 1353

页数：16

共 50 条

[31] Study of deferoxamine in subcutaneous profusion treatment of iron overload in myelodysplastic syndromes
González, FA
Arrizabalaga, B
Villegas, A
Alonso, D
Castro, M
Remacha, A
del Arco, A
Núñez, GM
MEDICINA CLINICA, 2005, 124 (17): : 645 - 647
[32] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
Roy, Noemi B. A.
Myerson, Saul
Schuh, Anna H.
Bignell, Patricia
Patel, Roger
Wainscoat, Jim S.
McGowan, Simon
Marchi, Emanuele
Atoyebi, Wale
Littlewood, Tim
Chacko, Joseph
Vyas, Paresh
Killick, Sally B.
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
[33] Management of Transfusion-Related Iron Overload in Patients With Myelodysplastic Syndromes
Shah, Jayshree
Kurtin, Sandra E.
Arnold, Louise
Lindroos-Kolqvist, Petra
Tinsley, Sara
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (03) : 37 - 46
[34] Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes
Angelucci, Emanuele
Cianciulli, Paolo
Finelli, Carlo
Mecucci, Cristina
Voso, Maria Teresa
Tura, Sante
LEUKEMIA RESEARCH, 2017, 62 : 108 - 115
[35] Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy
Jabbour, Elias
Garcia-Manero, Guillermo
Taher, Ali
Kantarjian, Hagop M.
ONCOLOGIST, 2009, 14 (05): : 489 - 496
[36] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Gattermann, Norbert
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (01) : 24 - 29
[37] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Norbert Gattermann
International Journal of Hematology, 2008, 88 : 24 - 29
[38] Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes
Gu, Shucheng
Xv, Yanjun
Fei, Chengming
Xiao, Chao
Guo, Juan
Zhao, Youshan
Xv, Feng
Li, Xiao
Chang, Chunkang
HEMATOLOGY, 2017, 22 (01) : 9 - 15
[39] Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy
Shammo, Jamile M.
Komrokji, Rami S.
EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (07) : 577 - 586
[40] Iron overload in myelodysplastic
Rachmilewitz, E. A.
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (06) : 553 - 553

← 1 2 3 4 5 →